The graphic below is part of my ongoing effort not only to maintain a list of all the volatility-based exchange-traded products, but present them in a manner which helps to highlight the distinctions among these products.
Since I last updated this picture in early December, three new VIX-based ETPs have entered the fold. Two of these are the first VIX-based ETFs and also represent the first products in this space from industry heavyweight and leveraged/inverse ETF heavyweight ProShares:
As the chart below shows, VIXY enters the already-crowded space of VIX-based ETPs targeting VIX futures with one month maturity, while VIXM is aimed at the five-month maturity space. ProShares undoubtedly hopes that by differentiating its products as ETFs rather than ETNs, the absence of credit risk associated with ETNs will resonate with investors. I have highlighted this distinction by using black italics for the ticker symbol of both ETFs.
ProShares has also been fortunate in that, as of this week, options are now being offered on VIXY and VIXM, making these only the third and fourth optionable volatility-based ETPs, following in the footsteps of VXX and VXZ. Note that all four optionable ETPs have a red "O" preceding their tickers.
The third new product to be launched in the past month is the iPath Inverse January 2021 S&P 500 VIX Short-Term Futures ETN, which trades under the ticker IVO. The launch of this ETN apparently confused some observers, but is likely an attempt by Barclays to come up with an ETF that does a better job of tracking the inverse of VXX. My concern is that over time IVOs ability to mirror changes in VXX will undergo the same dilution that happened to XXV.
It is possible that Barclays will periodically trot out newer versions of XXV and IVO, but until then, I see these two products as performing more like a fractional inverse ETN than XIV. For this reason, I have put XXV and IVO in separate boxes in the one month -1x space to reflect this important distinction (see here for more details.)